Literature DB >> 12117965

Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Prema Robinson1, A Clinton White, Dorothy E Lewis, John Thornby, Elliott David, Joel Weinstock.   

Abstract

Neurocysticercosis, a parasitic infection of the human central nervous system caused by Taenia solium, is a leading cause of seizures. Seizures associated with neurocysticercosis are caused mainly by the host inflammatory responses to dying parasites in the brain parenchyma. We previously demonstrated sequential expression of Th1 cytokines in early-stage granulomas, followed by expression of Th2 cytokines in later-stage granulomas in murine cysticercosis. However, the mechanism leading to this shift in cytokine response in the granulomas is unknown. Neuropeptides modulate cytokine responses and granuloma formation in murine schistosomiasis. Substance P (SP) induces Th1 cytokine expression and granuloma formation, whereas somatostatin inhibits the granulomatous response. We hypothesized that neuropeptides might play a role in regulation of the granulomatous response in cysticercosis. To test this hypothesis, we compared expression of SP and expression of somatostatin in murine cysticercal granulomas by using in situ hybridization and immunohistochemistry. We also compared expression with granuloma stage. Expression of SP mRNA was more frequent in the early-stage granulomas than in the late-stage granulomas (34 of 35 early-stage granulomas versus 1 of 13 late-stage granulomas). By contrast, somatostatin was expressed primarily in later-stage granulomas (13 of 14 late-stage granulomas versus 2 of 35 early-stage granulomas). The median light microscope grade of SP mRNA expression in the early-stage granulomas was significantly higher than that in the late-stage granulomas (P = 0.008, as determined by the Wilcoxon signed rank test). By contrast, somatostatin mRNA expression was higher at later stages (P = 0.008, as determined by the Wilcoxon signed rank test). SP and somatostatin are therefore temporally expressed in granulomas associated with murine cysticercosis, which may be related to differential expression of Th1 and Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117965      PMCID: PMC128166          DOI: 10.1128/IAI.70.8.4534-4538.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management.

Authors:  A C White
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.

Authors:  C Ripamonti; S Mercadante; L Groff; E Zecca; F De Conno; A Casuccio
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

3.  Somatostatin and substance P induced in vivo by lipopolysaccharide and in peritoneal macrophages stimulated with lipopolysaccharide or interferon-gamma have differential effects on murine cytokine production.

Authors:  S Y Ryu; K S Jeong; W K Yoon; S J Park; B N Kang; S H Kim; B K Park; S W Cho
Journal:  Neuroimmunomodulation       Date:  2000       Impact factor: 2.492

4.  Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors.

Authors:  A Vezzani; M Rizzi; M Conti; R Samanin
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

5.  Host response in childhood neurocysticercosis. Some pathological aspects.

Authors:  C R Sanz
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

6.  Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity.

Authors:  M K Tallent; G R Siggins
Journal:  J Neurophysiol       Date:  1999-04       Impact factor: 2.714

Review 7.  Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis.

Authors:  A Vezzani; D Hoyer
Journal:  Eur J Neurosci       Date:  1999-11       Impact factor: 3.386

8.  Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.

Authors:  A C White; P Robinson; P C Okhuysen; D E Lewis; I Shahab; S Lahoti; H L DuPont; C L Chappell
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

Authors:  P Honore; S D Rogers; M J Schwei; J L Salak-Johnson; N M Luger; M C Sabino; D R Clohisy; P W Mantyh
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

10.  Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P.

Authors:  J V Weinstock; A Blum; J Walder; R Walder
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

View more
  14 in total

1.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

2.  Neurocysticercosis.

Authors:  Vincent C Marconi; Hector H Garcia; Joel T Katz
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 3.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

4.  Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment.

Authors:  Miguel A Orrego; Manuela R Verastegui; Carlos M Vasquez; Hector H Garcia; Theodore E Nash
Journal:  Int J Parasitol       Date:  2022-02-17       Impact factor: 4.330

Review 5.  Neurocysticercosis: current knowledge and advances.

Authors:  Wayne X Shandera; Joseph S Kass
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

6.  Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.

Authors:  Armandina Garza; David J Tweardy; Joel Weinstock; Balaji Viswanathan; Prema Robinson
Journal:  J Biomed Biotechnol       Date:  2010-01-28

7.  Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection.

Authors:  Armandina Garza; Joel Weinstock; Prema Robinson
Journal:  J Parasitol       Date:  2008-12       Impact factor: 1.276

8.  Substance P causes seizures in neurocysticercosis.

Authors:  Prema Robinson; Armandina Garza; Joel Weinstock; Jose A Serpa; Jerry Clay Goodman; Kristian T Eckols; Bahrom Firozgary; David J Tweardy
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

9.  ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression data.

Authors:  Haseeb Ahmad Khan
Journal:  Comp Funct Genomics       Date:  2004

10.  Genome-wide analyses of gene expression during mouse endochondral ossification.

Authors:  Claudine G James; Lee-Anne Stanton; Hanga Agoston; Veronica Ulici; T Michael Underhill; Frank Beier
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.